eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Gilead Sciences Ltd
Flowers Building, Granta Park, Abington, Cambridge, Cambridge, CB21 6GT, UK
Telephone: +44 (0)1223 897 300
Fax: +44 (0)1223 897 291
Medical Information Direct Line: +44 (0)1223 897 555
Medical Information e-mail: ukmedinfo@gilead.com
Customer Care direct line: +44 (0)1223 897 400
Medical Information Fax: +44 (0)1223 897 281

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 28/12/2011
PIL AmBisome

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to date of revision
Updated on 24/10/2011 and displayed until 28/12/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 18/05/2011 and displayed until 24/10/2011
Reasons for adding or updating:
  • Change to packaging
  • Change to date of revision
Updated on 09/08/2010 and displayed until 18/05/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to dosage and administration
Updated on 29/05/2009 and displayed until 09/08/2010
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to date of revision
  • Change to manufacturer contact details
Updated on 07/11/2008 and displayed until 29/05/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to dosage and administration
  • Changes to therapeutic indications
Updated on 11/09/2008 and displayed until 07/11/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 13/09/2007 and displayed until 11/09/2008
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 27/09/2006 and displayed until 13/09/2007
Reasons for adding or updating:
  • Change to storage instructions
Updated on 17/11/2004 and displayed until 27/09/2006
Reasons for adding or updating:
  • Change to date of revision
Updated on 15/09/2004 and displayed until 17/11/2004
Reasons for adding or updating:
  • Change to storage instructions
Updated on 04/04/2002 and displayed until 15/09/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  amphotericin b